SCHEMBL9011018

SCHEMBL9011018

O=C(O)CCc1cccc(C2(O)CCN(C(=O)c3ccc4ccccc4c3)CC2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.54
DRD4 P21917 3/20 0.50
PARP10 Q53GL7 1/20 0.50
LMNA P02545 4/20 0.48
TSHR P16473 2/20 0.48
HPGD P15428 1/20 0.47
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA7 P43166 2/20 0.47
CA9 Q16790 2/20 0.47
CA14 Q9ULX7 1/20 0.47
AKR1C1 Q04828 1/20 0.46
RAB9A P51151 1/20 0.46
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.44
KMT2A Q03164 1/20 0.44
CAPN1 P07384 1/20 0.43
CTSB P07858 1/20 0.43
USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9011003 0.94 NPC1 (0.52) NPC1DRD4PARP10LMNATSHR
SCHEMBL9011057 0.90 NPC1 (0.52) NPC1DRD4PARP10LMNATSHR
SCHEMBL9011281 0.89 NPC1 (0.56) NPC1DRD4PARP10LMNATSHR
SCHEMBL27302984 0.85 CA12 (0.61) NPC1DRD4PARP10LMNATSHR
SCHEMBL7804418 0.85 PARP10 (0.52) NPC1DRD4PARP10LMNATSHR
SCHEMBL9011211 0.84 DRD4 (0.53) NPC1DRD4PARP10LMNATSHR
SCHEMBL7804501 0.84 PARP10 (0.52) NPC1PARP10LMNATSHRHPGD
SCHEMBL7811333 0.82 PARP10 (0.54) NPC1PARP10LMNATSHRHPGD
SCHEMBL9011135 0.82 TSHR (0.49) NPC1DRD4PARP10LMNATSHR
SCHEMBL9011210 0.81 NPC1 (0.54) NPC1DRD4PARP10LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed